Tell the good from the bad on compounded GLP-1 drugs
Vazquez F, Lim JH, Chim H, Bhalla K, Girnun G, Pierce K et al
25 Although data from clinical studies on liraglutide revealed a 7% increase in serum amylase and a 31% increase in serum lipase in patients after four weeks of GLP-1 receptor agonist treatment compared with placebo, the increased levels reverted to normal once therapy was discontinued and did not predict acute pancreatitis onset
Yadav, V., Marracci, G., Lovera, J., Woodward, W., Bogardus, K., Marquardt, W., Shinto, L., Morris, C., & Bourdette, D
& Rehman, M
(2) Nakamura A, Nakashima M, Sugao T, Kanemoto H, Fukumura Y, Shiomi H